While they're not the typical sufferers one thinks of when one hears about the rampant abuse of opioids in the country today, Medicare beneficiaries should be included in the picture — and they could be getting the short end of the stick when it comes to help.
Kaiser Health News reported that a research letter published by JAMA Psychiatry said that the beneficiaries of Medicare have the highest, and the fastest-growing, rate of "opioid use disorder." One out of every thousand patients covered by commercial insurance plans is a sufferer, but among Medicare patients, that number swells to 6 out of every 1,000.
The letter said that Medicare beneficiaries could be falling through the cracks when it comes to treatment, too. While 2013 saw a high level of opioid prescription painkillers for Medicare patients, doctors were far less often prescribing buprenorphine-naloxone, which is the only effective drug therapy for opioid use disorder covered by Medicare Part D.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
